Scientists decode TREX which could see new treatments for cancer realized

Aug 14, 2012

University of Sheffield scientists have decoded the processes which create proteins in all forms of life which - for the first time - opens the door to fixing these problems which can cause fatal health problems like Motor Neuron Disease, myotonic dystrophy and cancer.

Decoded process could hold the key to future treatments for a wide range of including , myotonic dystrophy and a wide range of cancers, University of Sheffield scientists have revealed.

Experts from the University's Department of Molecular Biology and Biotechnology, collaborating with scientists from Harvard Medical School in the USA, have revealed how a complicated set of proteins called TREX act as a passport for the transfer of cell blueprints which create proteins that are essential for life.

The researchers believe their better understanding will mean they can ultimately fix problems in the process which cause fatal like Motor Neuron Disease, myotonic dystrophy and a wide range of cancers.

Professor Stuart Wilson, who led the groundbreaking project, said: " is an essential part of life for all organisms. This process involves reading the code in genes and converting this to a message which is ultimately decoded to make a .

"The message is made of a special molecule called mRNA. In all from yeast through to man the mRNA is made in a compartment in the cell called the , but then has to be transported to a separate compartment, called the cytoplasm, where it is decoded to make a protein. This process of mRNA transport is essential for life and when it malfunctions in humans it can lead to diseases such as Motor Neuron Disease or cancer."

Researchers have shown how proteins called TREX provide a mark on the mRNA which acts as the passport which unlocks a transporter protein called Nxf1, allowing it to land on the mRNA and transport it to the cytoplasm to create proteins.

Professor Wilson added: "When a car is built in a factory, it goes through various stages of production with parts being added and, hopefully, quality control checks before it is driven out of the factory and into the salesroom.

"Similarly mRNA goes through various modifications in the nucleus, with bits added on and other sections removed. Only when the mRNA reaches the end of the production line in the nucleus and passes all the quality control checks is it given the passport which allows it to be transported to the cytoplasm and then used to make proteins.

"Until now, it has not been clear how the cell knows when the mRNA has reached the end of the production line in the nucleus and thus when it should be given a passport allowing passage to the . Now we have identified how the passport is issued, allowing the mRNA transport and the production of proteins in the cell which is essential for life."

The research is being published this week in Nature Communications.

Explore further: The origin of the language of life

Related Stories

How molecules get to the right place at the right time

Apr 20, 2011

Active transport processes in cells ensure that proteins with specialized local functions reach their intracellular destinations. Impaired transport causes cellular dysfunction or even cell death. Scientists from Ludwig-Maximilians-Universitaet ...

Mutant host cell protein sequesters critical HIV-1 element

Jan 15, 2009

Scientists have identified a new way to inhibit a molecule that is critical for HIV pathogenesis. The research, published by Cell Press in the January 16th issue of the journal Molecular Cell, presents a target for develo ...

Recommended for you

The origin of the language of life

Dec 19, 2014

The genetic code is the universal language of life. It describes how information is encoded in the genetic material and is the same for all organisms from simple bacteria to animals to humans. However, the ...

Quest to unravel mysteries of our gene network

Dec 18, 2014

There are roughly 27,000 genes in the human body, all but a relative few of them connected through an intricate and complex network that plays a dominant role in shaping our physiological structure and functions.

EU court clears stem cell patenting

Dec 18, 2014

A human egg used to produce stem cells but unable to develop into a viable embryo can be patented, the European Court of Justice ruled on Thursday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.